Skip to main content
. 2020 May 14;26(18):2232–2246. doi: 10.3748/wjg.v26.i18.2232

Table 3.

Clinicopathologic factors depending on the distance from the proximal resection margin in patients who underwent curative total gastrectomy, n (%)

Variables PRM (cm)
P value
≤ 1.0 (n = 90) 1.1-3.0 (n = 209) 3.1-5.0 (n = 146) > 5.0 (n = 214)
Age (yr)1 at operation 57.1 ± 1.2 55.0 ± 0.9 54.6 ± 0.9 56.3 ± 0.9 0.330
Sex 0.364
Male 64 (71.1) 135 (64.6) 92 (63.0) 150 (70.1)
Female 26 (38.9) 74 (35.4) 54 (37.0) 64 (29.9)
Tumor location < 0.001
Upper 1/3 81 (90.0) 127 (60.8) 32 (21.9) 26 (12.1)
Middle 1/3 8 (8.9) 75 (35.9) 103 (70.5) 134 (62.6)
Lower 1/3 1 (1.1) 7 (3.3) 11 (7.5) 54 (25.2)
Borrmann type IV 17 (18.9) 37 (17.7) 14 (9.6) 12 (5.6) < 0.001
Tumor size (cm)1 8.1 ± 0.5 7.6 ± 0.3 7.0 ± 0.3 5.9 ± 0.2 < 0.001
T stage 0.873
T2 14 (15.6) 30 (14.4) 24 (16.4) 42 (19.6)
T3 44 (48.9) 100 (47.8) 67 (45.9) 99 (46.3)
T4 32 (35.6) 79 (37.8) 55 (37.7) 73 (34.1)
CLN1 30.7 ± 1.1 33.1 ± 1.0 32.2 ± 1.0 31.0 ± 0.7 0.216
N stage 0.495
N0 23 (25.6) 74 (35.4) 47 (32.2) 59 (27.6)
N1 14 (15.6) 35 (16.7) 21 (14.4) 40 (18.7)
N2 15 (16.7) 41 (19.6) 30 (20.5) 42 (19.6)
N3 38 (42.2) 59 (28.2) 48 (32.9) 73 (34.1)
AJCC stage 0.587
Stage I 8 (8.9) 19 (9.1) 14 (9.6) 25 (11.7)
Stage II 29 (32.2) 85 (40.7) 53 (35.3) 68 (31.8)
Stage III 53 (58.9) 105 (50.2) 79 (54.1) 121 (56.5)
Differentiation 0.082
Differentiated 29 (32.2) 55 (26.3) 34 (23.3) 74 (34.6)
Undifferentiated 61 (67.8) 154 (73.7) 112 (76.7) 140 (65.4)
LVi 57 (63.3) 108 (51.7) 75 (51.4) 120 (56.1) 0.231
PNi 54 (60.0) 101 (48.3) 92 (63.0) 97 (45.3) 0.002
Recurrence 44 (48.9) 80 (38.3) 48 (32.9) 79 (36.9) 0.648
Local recurrence 8 (8.9) 10 (4.6) 11 (6.9) 14 (6.2) 0.637
1

mean ± standard error. PRM: Proximal resection margin; RYGJ: Roux-en-Y gastrojejunostomy; CLN: Total number of collected lymph nodes; AJCC: American Joint Committee on Cancer; LVi: Lymphovascular invasion; PNi: Perineural invasion.